Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Canopy Growth Corp T.WEED

Alternate Symbol(s):  T.WEED.DB | CGC

Healthcare Cannabis
Canopy Growth Corporation is a cannabis company. It delivers innovative products with a focus on premium and mainstream cannabis brands, including Doja, 7ACRES, Tweed, and Deep Space, in addition to category-defining vaporizer technology made in Germany by Storz & Bickel. The principal activities of the Company are the production, distribution and sale of a diverse range of cannabis and cannabinoid-based products for both adult-use and medical purposes under a portfolio of distinct brands in Canada. Its Canada cannabis segment includes the production, distribution, and sale of a range of cannabis, hemp, and cannabis related products in Canada. International markets cannabis segment includes the production, distribution, and sale of a range of cannabis and hemp products internationally. Storz & Bickel segment includes the production, distribution, and sale of vaporizers. This Works segment includes the production, distribution and sale of beauty, skincare, wellness and sleep products.


TSX:WEED - Post by User

Canopy Growth Corp
Bullboard Posts
User Avatar Image
(0)
•••
Comment by PotStockeron Nov 10, 2015 4:27pm
83 Views
Post# 24278613

RE:RE:RE:Legalization might not be the best thing for CGC

RE:RE:RE:Legalization might not be the best thing for CGC
HealthCanada wrote:

What is 30% of canada's population? You think there is enough supply if it was legal? lol, even Aphria CEO in interview said he couldnt keep up with a demand if legalization came into place. And Tweed actually engulfs all other LP's in square footage as this link shows. 

 

https://news.liftcannabis.ca/2015/06/16/canada-approaches-1-million-sq-ft-of-medical-marijuana/



The square footage is double edge sword. If you have it too early, it will burn you out. If you have it too late, you will have less market share.

But it will be right on time, when the bill has been inked and under debate. In my opinion, cgc is way too early and it will burn 1/4 of its cash reserve every quarter.
Bullboard Posts
Dealroom for high-potential pre-IPO opportunities